Insider Transactions in Q1 2023 at Provention Bio, Inc. (PRVB)
Insider Transaction List (Q1 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 31
2023
|
Sessa Capital (Master), L.P. > 10% Shareholder |
SELL
Other acquisition or disposition
|
Direct |
3,000,000
-25.25%
|
-
|
|
Feb 13
2023
|
Francisco Leon Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
25,985
-1.63%
|
$259,850
$10.04 P/Share
|
|
Feb 13
2023
|
Francisco Leon Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
25,985
+1.6%
|
$51,970
$2.5 P/Share
|
|
Feb 13
2023
|
Ashleigh Palmer Director and CEO |
SELL
Open market or private sale
|
Direct |
25,835
-1.0%
|
$258,350
$10.04 P/Share
|
|
Feb 13
2023
|
Ashleigh Palmer Director and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
25,835
+0.99%
|
$51,670
$2.5 P/Share
|
|
Feb 10
2023
|
Francisco Leon Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
50,000
-3.08%
|
$500,000
$10.11 P/Share
|
|
Feb 10
2023
|
Francisco Leon Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
50,000
+2.99%
|
$100,000
$2.5 P/Share
|
|
Feb 10
2023
|
Jason Hoitt Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
4,500
-100.0%
|
$45,000
$10.0 P/Share
|
|
Feb 10
2023
|
Ashleigh Palmer Director and CEO |
SELL
Open market or private sale
|
Direct |
50,000
-1.91%
|
$500,000
$10.11 P/Share
|
|
Feb 10
2023
|
Ashleigh Palmer Director and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
50,000
+1.87%
|
$100,000
$2.5 P/Share
|
|
Jan 18
2023
|
Francisco Leon Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
24,015
-1.5%
|
$240,150
$10.27 P/Share
|
|
Jan 18
2023
|
Francisco Leon Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
24,015
+1.48%
|
$48,030
$2.5 P/Share
|
|
Jan 18
2023
|
Ashleigh Palmer Director and CEO |
SELL
Open market or private sale
|
Direct |
24,165
-0.93%
|
$241,650
$10.27 P/Share
|
|
Jan 18
2023
|
Ashleigh Palmer Director and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
24,165
+0.92%
|
$48,330
$2.5 P/Share
|
|
Jan 18
2023
|
Sessa Capital (Master), L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
3,000,000
-20.16%
|
$27,000,000
$9.4 P/Share
|